Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study

Background The UK's Quality and Outcomes Framework (QOF) was introduced in 2004/5, linking remuneration for general practices to recorded quality of care for chronic conditions, including diabetes mellitus. We assessed the effect of the incentives on recorded quality of care for diabetes patients and its variation by patient and practice characteristics. Methods Using the General Practice Research Database we selected a stratified sample of 148 English general practices in England, contributing data from 2000/1 to 2006/7, and obtained a random sample of 653 500 patients in which 23 920 diabetes patients identified. We quantified annually recorded quality of care at the patient-level, as measured by the 17 QOF diabetes indicators, in a composite score and analysed it longitudinally using an Interrupted Time Series design. Results Recorded quality of care improved for all subgroups in the pre-incentive period. In the first year of the incentives, composite quality improved over-and-above this pre-incentive trend by 14.2% (13.7–14.6%). By the third year the improvement above trend was smaller, but still statistically significant, at 7.3% (6.7–8.0%). After 3 years of the incentives, recorded levels of care varied significantly for patient gender, age, years of previous care, number of co-morbid conditions and practice diabetes prevalence. Conclusions The introduction of financial incentives was associated with improvements in the recorded quality of diabetes care in the first year. These improvements included some measures of disease control, but most captured only documentation of recommended aspects of clinical assessment, not patient management or outcomes of care. Improvements in subsequent years were more modest. Variation in care between population groups diminished under the incentives, but remained substantial in some cases.

[1]  Martin Roland,et al.  Linking physicians' pay to the quality of care--a major experiment in the United kingdom. , 2004, The New England journal of medicine.

[2]  X. Cos,et al.  Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centres (GEDAPS study): ten year-implementation of St. Vincent recommendations. , 2012, Primary care diabetes.

[3]  Stephen Campbell,et al.  Is the quality of care in general medical practice improving? Results of a longitudinal observational study. , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[4]  Tim Doran,et al.  Does higher quality of diabetes management in family practice reduce unplanned hospital admissions? , 2011, Health services research.

[5]  A. Majeed,et al.  Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions , 2009, Journal of the Royal Society of Medicine.

[6]  P. Seed,et al.  The relationship between social deprivation and the quality of primary care: a national survey using indicators from the UK Quality and Outcomes Framework. , 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

[7]  D. Collett,et al.  Modelling Binary Data , 1991 .

[8]  S. Capewell,et al.  018 Forecasting diabetes prevalence using a simple model: England and Wales 1993–2006 , 2010, Journal of Epidemiology & Community Health.

[9]  Nick Freemantle,et al.  Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study , 2009, BMJ : British Medical Journal.

[10]  W. Shadish,et al.  Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .

[11]  Sheila Leatherman,et al.  Lessons From Evaluations of Purchaser Pay-for-Performance Programs , 2008, Medical care research and review : MCRR.

[12]  A. Zaslavsky,et al.  Trends in the quality of care and racial disparities in Medicare managed care. , 2005, The New England journal of medicine.

[13]  Paul Shekelle,et al.  New contract for general practitioners , 2003, BMJ : British Medical Journal.

[14]  D. Reeves,et al.  Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework , 2008, The Lancet.

[15]  Anthea,et al.  Impact of a Pay-for-Performance Incentive Scheme on Age, Sex, and Socioeconomic Disparities in Diabetes Management in UK Primary Care , 2010, The Journal of ambulatory care management.

[16]  Barry Turner,et al.  Civitas (Institute for the Study of Civil Society) , 2011 .

[17]  Madhavi Bajekal,et al.  Health Survey for England , 2004 .

[18]  B. Starfield,et al.  Defining Comorbidity: Implications for Understanding Health and Health Services , 2009, The Annals of Family Medicine.

[19]  M. Roland,et al.  Lessons from major initiatives to improve primary care in the United Kingdom. , 2010, Health affairs.

[20]  Evangelos Kontopantelis,et al.  Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework , 2011, BMJ : British Medical Journal.

[21]  Evangelos Kontopantelis,et al.  Quality of primary care in England with the introduction of pay for performance. , 2007, The New England journal of medicine.

[22]  Vasa Curcin,et al.  Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care , 2011, Canadian Medical Association Journal.

[23]  Evangelos Kontopantelis,et al.  Pay-for-performance programs in family practices in the United Kingdom. , 2006, The New England journal of medicine.

[24]  B. Sibbald,et al.  Effects of pay for performance on the quality of primary care in England. , 2009, The New England journal of medicine.

[25]  A K Wagner,et al.  Segmented regression analysis of interrupted time series studies in medication use research , 2002, Journal of clinical pharmacy and therapeutics.